961 results on '"Blakely, Randy D."'
Search Results
2. Perivascular niche cells sense thrombocytopenia and activate hematopoietic stem cells in an IL-1 dependent manner
3. Functional and pathological consequences of being fast on the uptake: Protein kinase G and p38α MAPK regulation of serotonin transporters
4. Serotonin-releasing agents with reduced off-target effects
5. Divergent Actions of Renal Tubular and Endothelial Type 1 IL-1 Receptor Signaling in Toxin-Induced AKI
6. Behaviorally penetrant, anomalous dopamine efflux exposes sex and circuit dependent regulation of dopamine transporters
7. Regulation of autism-relevant behaviors by cerebellar–prefrontal cortical circuits
8. Novel anti-inflammatory effects of the IL-1 receptor in kidney myeloid cells following ischemic AKI
9. Serotonin Transporter Ala276 Mouse: Novel Model to Assess the Neurochemical and Behavioral Impact of Thr276 Phosphorylation In Vivo
10. Optical Imaging Demonstrates Tissue-Specific Metabolic Perturbations in Mblac1 Knockout Mice
11. Serotonin 5-HT1B receptor-mediated behavior and binding in mice with the overactive and dysregulated serotonin transporter Ala56 variant
12. Sink or swim: Does a worm paralysis phenotype hold clues to neurodegenerative disease?
13. Novel anti-inflammatory effects of the IL-1 receptor in kidney myeloid cells following ischemic AKI.
14. Long COVID-19 and Peripheral Serotonin: A Commentary and Reconsideration.
15. Glialswip-10expression controls systemic mitochondrial function, oxidative stress, and neuronal viability via copper ion homeostasis
16. Leaky lessons learned: Efflux prone dopamine transporter variant DAT Val559 reveals sex and circuit specific contributions of D2 receptor signaling to neuropsychiatric disease
17. p38α MAPK signaling drives pharmacologically reversible brain and gastrointestinal phenotypes in the SERT Ala56 mouse
18. Disruption of Transient Serotonin Accumulation by Non-Serotonin-Producing Neurons Impairs Cortical Map Development.
19. Blockade and reversal of swimming-induced paralysis in C. elegans by the antipsychotic and D2-type dopamine receptor antagonist azaperone
20. Leaky lessons learned: Efflux prone dopamine transporter variant reveals sex and circuit specific contributions of D2 receptor signalling to neuropsychiatric disease.
21. Fluoxetine restrains allergic inflammation by targeting an FcɛRI-ATP positive feedback loop in mast cells
22. Disruptive mutations in the serotonin transporter associate serotonin dysfunction with treatment-resistant affective disorder
23. Optical Imaging Reveals Liver Metabolic Perturbations in Mblac1 Knockout Mice
24. Genetic background modulates phenotypes of serotonin transporter Ala56 knock-in mice
25. Pancreatic deletion of the interleukin-1 receptor disrupts whole body glucose homeostasis and promotes islet β-cell de-differentiation
26. Serotonin transporter inhibition and 5-HT2C receptor activation drive loss of cocaine-induced locomotor activation in DAT Val559 mice
27. Spatial gene expression analysis of neuroanatomical differences in mouse models
28. Human Serotonin Transporter Variants Display Altered Sensitivity to Protein Kinase G and p38 Mitogen-Activated Protein Kinase
29. Amphetamine Induces Dopamine Efflux through a Dopamine Transporter Channel
30. Dopamine Transporters Depolarize Neurons by a Channel Mechanism
31. Lethal Impairment of Cholinergic Neurotransmission in Hemicholinium-3-Sensitive Choline Transporter Knockout Mice
32. Neurotoxin-Induced Degeneration of Dopamine Neurons in Caenorhabditis elegans
33. Phosphorylation and Sequestration of Serotonin Transporters Differentially Modulated by Psychostimulants
34. Patch-Clamp and Amperometric Recordings from Norepinephrine Transporters: Channel Activity and Voltage-Dependent Uptake
35. Norepinephrine Transporters have Channel Modes of Conduction
36. Differential impact of genetically modulated choline transporter expression on the release of endogenous versus newly synthesized acetylcholine
37. Acute blockade of the Caenorhabditis elegans dopamine transporter DAT-1 by the mammalian norepinephrine transporter inhibitor nisoxetine reveals the influence of genetic modifications of dopamine signaling in vivo
38. Male DAT Val559 Mice Exhibit Compulsive Behavior under Devalued Reward Conditions Accompanied by Cellular and Pharmacological Changes
39. Serotonin-releasing agents with reduced off-target effects
40. DAT Val559 Mice Exhibit Compulsive Behavior Under Devalued Reward Conditions Accompanied by Cellular and Pharmacological Changes
41. The rare DAT coding variant Val559 perturbs DA neuron function, changes behavior, and alters in vivo responses to psychostimulants
42. Serotonin-releasing agents with reduced off-target effects
43. Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: On the path to an animal model of attention-deficit hyperactivity disorder
44. Transgenic overexpression of the presynaptic choline transporter elevates acetylcholine levels and augments motor endurance
45. Good riddance to dopamine: Roles for the dopamine transporter in synaptic function and dopamine-associated brain disorders
46. Dopamine's Reversal of Fortune
47. Functional coding variation in the presynaptic dopamine transporter associated with neuropsychiatric disorders drives enhanced motivation and context-dependent impulsivity in mice
48. Choline transporter mutations in severe congenital myasthenic syndrome disrupt transporter localization
49. Analysis of neuroanatomical differences in mice with genetically modified serotonin transporters assessed by structural magnetic resonance imaging
50. Serotonin transporter variant drives preventable gastrointestinal abnormalities in development and function
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.